SAN DIEGO — Patients with atopic dermatitis (AD) are at a significantly higher risk for nonmelanoma skin cancer (NMSC), ...

Pharmaceutical company Organon (NYSE:OGN) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales ...

Two studies explored the quality-of-life impacts of lebrikizumab for atopic dermatitis, finding its benefits extend beyond ...

A new study conducted by researchers at National Jewish Health has found that early changes in the cheek skin barrier may ...

Patients with atopic dermatitis had an increased risk for COVID-19 infection despite age and sex, and some comorbidities were linked to a greater risk.

Salt water may help exfoliate facial skin and treat certain skin diseases. Learn the science behind what it does and does not ...

Phase 2 APEX trial of APG777 in atopic dermatitis advancing with interim Part A 16-week data expected in mid-2025 and Part B actively enrolling First patient dosed in Phase 1b trial of APG777 in ...

Atopic dermatitis causes flaky, itchy, dry, and inflamed skin. It can look different on darker skin, making it harder to spot ...

Eczema on dark skin looks different and is often misdiagnosed, leading to pigment changes, emotional stress, and poor ...

A newly developed Naples Pediatric Food Allergy grading scale, incorporating clinical history and examination, shows promise in streamlining the diagnosis of food allergies in children, potentially ...

Corvus reported strong Phase 1 results for soquelitinib in atopic dermatitis, with early efficacy and no major safety concerns across all dose groups.

SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a business update and reported ...